Itopride Supremex

Itopride, the active ingredient in Itopride Supremex, is a prokinetic agent presented as an oral tablet for oral use. It is indicated for functional dyspepsia, where it enhances gastrointestinal motility to alleviate upper‑abdominal discomfort in adult patients. The product is formulated for convenient oral administration and is marketed within the European Union.

GNH USA supplies Itopride Supremex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance across European and global markets.

Itopride acts on gastrointestinal motility disorders, particularly functional dyspepsia and its sub‑categories.

- Functional dyspepsia: improves gastric emptying and reduces upper‑abdominal discomfort in affected patients. - Post‑prandial distress syndrome: alleviates early satiety and fullness after meals. - Epigastric pain syndrome: reduces epigastric pain associated with dyspeptic conditions.

Itopride is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Diarrhea: loose stools occurring intermittently. - Abdominal pain: discomfort or cramps in the stomach area. - Headache: mild to moderate head pain. - Dry mouth: reduced salivation. - Dizziness: sensation of light‑headedness.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm, potentially serious. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Extrapyramidal symptoms: involuntary muscle movements. - Elevated liver enzymes: indication of hepatic stress. - Pancreatitis: inflammation of the pancreas. - Severe hypotension: marked drop in blood pressure.

Before initiating therapy, consider the following precautions.

- Assess renal function: adjust use if renal impairment is present. - Monitor cardiac status: be vigilant in patients with known heart disease. - Use caution in elderly: increased susceptibility to side effects. - Avoid concomitant dopamine antagonists: may diminish therapeutic effect. - Discontinue if severe allergic reaction occurs: seek immediate medical attention. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Itopride may interact with several medication classes.

Major Interactions (Avoid): - Antipsychotics (e.g., haloperidol): may reduce prokinetic efficacy. - Strong CYP3A4 inhibitors (e.g., ketoconazole): can increase plasma concentrations. - MAO inhibitors: risk of hypertensive crisis when combined.

Moderate Interactions (Monitor Closely): - Anticholinergics: may diminish the drug’s prokinetic action. - Other prokinetic agents: additive effects could lead to excessive motility. - Warfarin: monitor INR for potential anticoagulation changes.